{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T23:52:49Z","timestamp":1773445969684,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW 113-TDU-B-221-124003"],"award-info":[{"award-number":["MOHW 113-TDU-B-221-124003"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["112-TMU151"],"award-info":[{"award-number":["112-TMU151"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jfma.2025.01.001","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T16:09:04Z","timestamp":1736438944000},"page":"800-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma"],"prefix":"10.1016","volume":"124","author":[{"given":"Pei-Jui","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8020-7970","authenticated-orcid":false,"given":"Kai-I","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Fu","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Yu","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5755-9062","authenticated-orcid":false,"given":"Ming-Shun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Yu","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5506-4293","authenticated-orcid":false,"given":"Wei-Yu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7498-4183","authenticated-orcid":false,"given":"Chih-Horng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jfma.2025.01.001_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"22","key":"10.1016\/j.jfma.2025.01.001_bib2","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/cncr.30237","article-title":"Comparison of hepatocellular carcinoma in Eastern versus Western populations","volume":"122","author":"Choo","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jfma.2025.01.001_bib3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jfma.2020.10.031","article-title":"Systemic therapy group. Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the taiwan liver cancer association and the gastroenterological society of taiwan","volume":"120","author":"Shao","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"10.1016\/j.jfma.2025.01.001_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","article-title":"Systemic treatment of hepatocellular carcinoma: an EASL position paper","volume":"75","author":"Bruix","year":"2021","journal-title":"J Hepatol"},{"issue":"1 Pt 1","key":"10.1016\/j.jfma.2025.01.001_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jfma.2020.07.009","article-title":"It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade","volume":"120","author":"Liu","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"10126","key":"10.1016\/j.jfma.2025.01.001_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jfma.2025.01.001_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2022.09.006","article-title":"Overall survival and objective response in advanced unresectable hepatocellular carcinoma: a subanalysis of the REFLECT study","volume":"78","author":"Kudo","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jfma.2025.01.001_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.jfma.2025.01.001_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2018.12.003","article-title":"Body composition and sarcopenia: the next-generation of personalized oncology and pharmacology?","volume":"196","author":"Hilmi","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jfma.2025.01.001_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139749","article-title":"Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jfma.2025.01.001_bib11","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3892\/ol.2017.6287","article-title":"Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy","volume":"14","author":"Nishikawa","year":"2017","journal-title":"Oncol Lett"},{"issue":"1 Pt 2","key":"10.1016\/j.jfma.2025.01.001_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jfma.2020.07.005","article-title":"Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma","volume":"120","author":"Wu","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"10.1016\/j.jfma.2025.01.001_bib13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00330-022-08980-4","article-title":"Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma","volume":"33","author":"Chen","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jfma.2025.01.001_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101398","article-title":"Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond sarcopenia","volume":"70","author":"Ahn","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"5","key":"10.1016\/j.jfma.2025.01.001_bib15","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/jcsm.12575","article-title":"Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis","volume":"11","author":"Lee","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jfma.2025.01.001_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102839","article-title":"Myosteatosis and prognosis in cancer: systematic review and meta-analysis","volume":"145","author":"Aleixo","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.jfma.2025.01.001_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","article-title":"Diagnostic criteria for malnutrition - an ESPEN consensus statement","volume":"34","author":"Cederholm","year":"2015","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.jfma.2025.01.001_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1148\/radiol.2017162382","article-title":"Hepatocellular carcinoma: nomograms based on the albumin-bilirubin grade to assess the outcomes of radiofrequency ablation","volume":"285","author":"Kao","year":"2017","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jfma.2025.01.001_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J Hepatol"},{"issue":"21","key":"10.1016\/j.jfma.2025.01.001_bib20","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.jfma.2025.01.001_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jfma.2025.01.001_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000503829","article-title":"Skeletal muscle loss during tyrosine kinase inhibitor treatment for advanced hepatocellular carcinoma patients","volume":"9","author":"Uchikawa","year":"2020","journal-title":"Liver Cancer"},{"issue":"4","key":"10.1016\/j.jfma.2025.01.001_bib23","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/nu13041196","article-title":"The clinical value of nutritional care before and during active cancer treatment","volume":"13","author":"Aprile","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.jfma.2025.01.001_bib24","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.3390\/ijms16059612","article-title":"Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib","volume":"16","author":"Imai","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jfma.2025.01.001_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000487858","article-title":"No muscle depletion with high visceral fat as a novel beneficial biomarker of sorafenib for hepatocellular carcinoma","volume":"7","author":"Saeki","year":"2018","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.jfma.2025.01.001_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000504604","article-title":"Skeletal muscle mass influences tolerability and prognosis in hepatocellular carcinoma patients treated with lenvatinib","volume":"9","author":"Uojima","year":"2020","journal-title":"Liver Cancer"},{"issue":"7","key":"10.1016\/j.jfma.2025.01.001_bib27","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/jgh.15336","article-title":"Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: analysis adjusted with inverse probability weighting","volume":"36","author":"Hiraoka","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jfma.2025.01.001_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196235","article-title":"Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas","volume":"13","author":"Stretch","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jfma.2025.01.001_bib29","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.dld.2019.09.004","article-title":"The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease","volume":"51","author":"Lattanzi","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.jfma.2025.01.001_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/ajt.15577","article-title":"Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation","volume":"20","author":"Czigany","year":"2020","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.jfma.2025.01.001_bib31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11605-015-2838-8","article-title":"Effect of intramuscular adipose tissue content on prognosis in patients undergoing hepatocellular carcinoma resection","volume":"19","author":"Kaibori","year":"2015","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.jfma.2025.01.001_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000488779","article-title":"Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma","volume":"8","author":"Hamaguchi","year":"2019","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.jfma.2025.01.001_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/cancers16020454","article-title":"The clinical significance of myosteatosis in survival outcomes in patients with hepatocellular carcinoma treated with sorafenib","volume":"16","author":"Kang","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.jfma.2025.01.001_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/hmbci-2015-0045","article-title":"Intramyocellular fat storage in metabolic diseases","volume":"26","author":"Laurens","year":"2016","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"4","key":"10.1016\/j.jfma.2025.01.001_bib35","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10753-014-9914-1","article-title":"Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions","volume":"37","author":"Ghigliotti","year":"2014","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.jfma.2025.01.001_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5493\/wjem.v3.i3.26","article-title":"Interplay of adipokines and myokines in cancer pathophysiology: emerging therapeutic implications","volume":"3","author":"Dalamaga","year":"2013","journal-title":"World J Exp Med"},{"issue":"8","key":"10.1016\/j.jfma.2025.01.001_bib37","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1158\/1078-0432.CCR-12-0930","article-title":"Molecular pathways: adiponectin and leptin signaling in cancer","volume":"19","author":"Vansaun","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.jfma.2025.01.001_bib38","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.clnu.2017.07.007","article-title":"Contrast-enhancement influences skeletal muscle density, but not skeletal muscle mass, measurements on computed tomography","volume":"37","author":"van Vugt","year":"2018","journal-title":"Clin Nutr"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T12:08:50Z","timestamp":1756210130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0929664625000014"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.01.001","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}